Karuna Therapeutics, Inc. Debt to Equity Ratio 2019-2023 | KRTX
Current and historical debt to equity ratio values for Karuna Therapeutics, Inc. (KRTX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Karuna Therapeutics, Inc. debt/equity for the three months ending December 31, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.08B | $1.25B | 0.07 |
| 2023-09-30 | $0.06B | $1.32B | 0.05 |
| 2023-06-30 | $0.05B | $1.42B | 0.04 |
| 2023-03-31 | $0.03B | $1.49B | 0.02 |
| 2022-12-31 | $0.04B | $1.13B | 0.03 |
| 2022-09-30 | $0.04B | $1.18B | 0.04 |
| 2022-06-30 | $0.03B | $0.41B | 0.07 |
| 2022-03-31 | $0.02B | $0.45B | 0.05 |
| 2021-12-31 | $0.03B | $0.50B | 0.05 |
| 2021-09-30 | $0.02B | $0.52B | 0.04 |
| 2021-06-30 | $0.02B | $0.56B | 0.03 |
| 2021-03-31 | $0.01B | $0.59B | 0.01 |
| 2020-12-31 | $0.01B | $0.34B | 0.03 |
| 2020-09-30 | $0.01B | $0.36B | 0.02 |
| 2020-06-30 | $0.01B | $0.37B | 0.02 |
| 2020-03-31 | $0.01B | $0.39B | 0.01 |
| 2019-12-31 | $0.00B | $0.39B | 0.01 |
| 2019-09-30 | $0.00B | $0.16B | 0.01 |
| 2019-06-30 | $0.13B | $-0.05B | -2.69 |
| 2019-03-31 | $0.00B | 0.00 | |
| 2018-09-30 | $0.00B | 0.00 | |
| 2018-06-30 | $0.00B | 0.00 | |
